Back

GL PharmTech shares plunge 8.65% after dry-eye drug wins approval

Verifying
  • GL PharmTech co-developed Recodu Eye Drops 5% with Ahn-Gook Pharmaceutical.
  • GL PharmTech shares fell 8.65% to 5,270 won on the 9th.
  • Domestic sales are scheduled for the second half of 2027 after pricing negotiations.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.